• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Relationship between polymorphisms of eNOS gene and depression

Research Project

Project/Area Number 19591385
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Psychiatric science
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

YOSHIMURA Reiji  University of Occupational and Environmental Health, Japan, 医学部, 准教授 (90248568)

Co-Investigator(Kenkyū-buntansha) 中村 純  産業医科大学, 医学部, 教授 (40148804)
後藤 直樹  産業医科大学, 医学部, 助教 (60360278)
中野 英樹  産業医科大学, 医学部, 助教 (20369060)
Co-Investigator(Renkei-kenkyūsha) NAKAMURA Jun  産業医科大学, 医学部, 教授 (40148804)
GOTO Naoki  産業医科大学, 医学部, 助教 (60360278)
NAKANO Hideki  産業医科大学, 医学部, 訪問研究員 (20369060)
SUGITA Atsuko  産業医科大学, 医学部, 非常勤助教 (40421333)
Project Period (FY) 2007 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2007: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords一酸化窒素 / 遺伝子多型 / うつ病 / 脳由来神経栄養因子 / ミルナシプラン / 血管由来一酸化窒素合成酵素
Research Abstract

Objective : We hypothesized that polymorphisms of eNOS gene are associated with pathogenesis of depression. To confirm the hypothesis, we examined the association of the polymorphisms of eNOS gene between patients with MDD. In addition, we also investigated the associations among the polymorphisms of eNOS gene among scores of HAMD and Beck Depression Inventory (BDI), ankle brachial index (ABI) and plasma NOx levels in depressed patients.
Materials and Methods : This study included 103 in- or outpatients in our university hospital who met the DSM-IV-TR criteria for MDD (M/F:41/62, age:44±13 years) and 104 age- and sex-matched healthy controls (M/F:37/66, age:39±16 years). Based on three polymorphism of eNOS gene (SNP; rs2070744, rs1799983, VNTR in intron 4), we conducted a genetic association analysis of case- control samples in patients with MDD or healthy controls in Japanese population. The plasma NOx levels were analyzed by the Griess method, using ENO-20. We used TaqMan assay for two SNPs, and the VNTR polymorphisms in intron 4 were determined by PCR-RFLP.
Results : We did not find genotype distributions between patients with MDD and healthy volunteers. No associations were observed between any polymorphisms of eNOS gene and HAMD, BDI, or ABI in patients with MDD. Conclusions : These results suggest that the three polymorphisms of eNOS gene might play little roles for the pathogenesis of depression.

Report

(4 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • 2007 Annual Research Report
  • Research Products

    (59 results)

All 2010 2009 2008 2007

All Journal Article (42 results) (of which Peer Reviewed: 42 results) Presentation (17 results)

  • [Journal Article] Associattion between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia:a pilot study.2010

    • Author(s)
      Nakano Y, Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 25

      Pages: 139-144

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serotonin 6 receptor gene and mood disorders:case control study and meta-analysis.2010

    • Author(s)
      Fukuo Y, Kishi T, Yoshimura R, et al.
    • Journal Title

      Neurosci Res (Epub ahead of print)

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Association analysis of SIGMA 1 with major depressive disorder and SSRI response.2010

    • Author(s)
      Kishi T, Yoshimura R, et al.
    • Journal Title

      Neuropharmacol 58

      Pages: 1168-1173

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Nonadrerence to paroxetine:a study based on monitoring plasma paroxetine levels.2010

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      J Clin Psychopharmacol 30

      Pages: 82-83

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.2010

    • Author(s)
      Yoshimura R, Ikenouchi-Sugita A, et al.
    • Journal Title

      P-N Biol Psychiatry 34

      Pages: 308-312

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Different patterns of longitudinal changes in plasma levels of catechola mine metabolites and brain-derived neurotrophic factor after administrations of atypical antipsychotics in first episode untreated schizophrenic patients.2010

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      World J Biol Psychiatry 11

      Pages: 256-261

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Associations between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia.2010

    • Author(s)
      Nakano Y, et al.
    • Journal Title

      Hum Psychopharmacol 25

      Pages: 139-144

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Opposite effects of milnacipran, a serotonin norepinephrine reuptake in hibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex.2010

    • Author(s)
      Ikenouchi-Sugita A, et al.
    • Journal Title

      N-S Arch Pharmacology 380

      Pages: 479-486

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association analysis of SIGMAR1 with major depressive disorder and SSRI response.2010

    • Author(s)
      Kishi T, et al.
    • Journal Title

      Neuropharmacology Feb 21

      Pages: 1168-1173

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythe matosus.2010

    • Author(s)
      Ikenouchi-Sugita A, et al.
    • Journal Title

      World J Biol Psychiatry Mar 11

      Pages: 121-128

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Nonadherence to paroxetine : a study based on monitoring plasma paroxetine levels.2010

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      J Clin Psychopharmacol 30

      Pages: 82-83

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.2010

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      P-N Biol Psychiatry 34

      Pages: 308-312

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia.2010

    • Author(s)
      Moriya J, et al.
    • Journal Title

      Schizophr Res 116

      Pages: 196-203

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia : integrated analysis among pharmacogenomics, mouse expression, and genetic case control study.2010

    • Author(s)
      Ikeda M, et al.
    • Journal Title

      Biol Psychiatry 67

      Pages: 263-269

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Predictive factors for responding sertraline treatment : views from catecholamine metabolites and serotonin transporter polymorphism.2010

    • Author(s)
      Umene-Nakano W, et al.
    • Journal Title

      J Psychopharmacol Oct 13(Epub.)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HTR2R is associated with SSRI response in major depressive disorder in a Japanese cohort.2009

    • Author(s)
      Kishi T, Yoshimura R, et al.
    • Journal Title

      Neuromolecular Med (Epub ahead of print)

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex.2009

    • Author(s)
      Ikenouchi-Sugita A, Yumiko T, Yoshimura R, et al.
    • Journal Title

      N-S Arch Pharmacol. N-S Arch Pharmacol 380

      Pages: 479-486

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Predictive factors for responding to sertraline treatment:views from plasma catecholamine metabolite and serotonin transporter polymorphism.2009

    • Author(s)
      Umene-Nakano A, Yoshimura R, et al.
    • Journal Title

      J Psychopharmacol (Epub ahead of print)

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of antidepressants on plasma metabolites of nitric oxide in major metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.2009

    • Author(s)
      Ikenouchi-Sugita A, Yoshimura R, et al.
    • Journal Title

      P-N Biol Psychiatry 33

      Pages: 1451-1453

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin promoter polymorphism in Japanese depressed patients.2009

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 24

      Pages: 489-494

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.2009

    • Author(s)
      Umene-Nakano W, Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 24

      Pages: 409-413

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Higher interleukin-6(IL-6) level is associated with SSRI-or SNRI-refractory depression.2009

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      P-N Biol Psychiatry 33

      Pages: 722-726

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] How many well day vs. unwell days can you expect over 10 years, once you become depressed?2009

    • Author(s)
      Furukawa TA, Yoshimura R, et al.
    • Journal Title

      Acta Psychiatr Scand 119

      Pages: 290-297

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol_(MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.2009

    • Author(s)
      Goto N, et al.
    • Journal Title

      Hum Psychopharmacol 24

      Pages: 639-645

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.2009

    • Author(s)
      Kishi T, et al.
    • Journal Title

      Neuromolecular Med Nov 24(Epub.)

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Trichotiliomania responding to low-dose fluvoxamine.2009

    • Author(s)
      Ikenouchi-Sugita A, et al.
    • Journal Title

      Psychiatry Clin Neurosci 63

      Pages: 701-702

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients : an open-label prospective study.2009

    • Author(s)
      Hori H, et al.
    • Journal Title

      World J Biol Psychiatry 10

      Pages: 741-745

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder : comparison between milnacipran and paroxetine.2009

    • Author(s)
      Ikenouchi-Sugita A, et al.
    • Journal Title

      P-N Biol Psychiatry 33

      Pages: 1451-1453

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but 8 weeks of treatment, and is independent of serotonin trans porter promoter polymorphism in Japanese depressed patients.2009

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 24

      Pages: 489-494

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.2009

    • Author(s)
      Umene-Nakano W, et al.
    • Journal Title

      Hum Psychopharmacol 24

      Pages: 409-413

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Reduction of brain gamma-aminobutylic acid (GABA) concentrations in early-stage schizophrenia patients : 3T Proton MRS study2009

    • Author(s)
      Goto N, et al.
    • Journal Title

      Schizophr Res 112

      Pages: 192-745193

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.2009

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      P-N Biol Psychiatry 33

      Pages: 722-726

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A case of late-onset Tourette's disorder successfully treated with aripipr azole : view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).2009

    • Author(s)
      Ikenouchi-Sugita A, et al.
    • Journal Title

      World J Biol Psychiatry 10

      Pages: 977-980

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers.2009

    • Author(s)
      Ueda N, et al.
    • Journal Title

      World J Biol Psychiatry 10

      Pages: 832-835

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adding of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.2008

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 23

      Pages: 707-713

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients:a pilot study.2008

    • Author(s)
      Okamoto T, Yoshimura R, et al.
    • Journal Title

      P-B Biol Psychiatry 32

      Pages: 1185-1190

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of electroconvulsive therapy is associated with changing blood leve Is of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depression2008

    • Author(s)
      Okamoto T, et al.
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry 32

      Pages: 1185-1190

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline2008

    • Author(s)
      Yoshimura R, et al.
    • Journal Title

      Hum Psychopharmacol 23

      Pages: 707-713

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers : BDNF and MHPG as possible biological markers of mental stress?2008

    • Author(s)
      Mitoma M, et al.
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry 32

      Pages: 679-685

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients2007

    • Author(s)
      Yoshimura R, et. al.
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry 31

      Pages: 1034-1037

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxyphenylglycol(MHPG)levels,but did not alter piasma brain-derived neurotrophic factor(BDNF)Ievels in schizophrenia2007

    • Author(s)
      Yoshimura R, et. al.
    • Journal Title

      Prog Neuropsychopharmacol Biol Psychiatry 31

      Pages: 1072-1077

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Valproic acid improves psychotic agitatioh without influencing plasma risperidone levels in schizophrenic patients2007

    • Author(s)
      Yoshimura R, et. al.
    • Journal Title

      Pharmacopsychiatry 40

      Pages: 9-13

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Presentation] セロトニン・ノルアドレナリン再取り込み阻害薬ミルナシプランの脳内NOSおよびBDNFに対する影響.2009

    • Author(s)
      豊平由美子, ほか
    • Organizer
      第62回日本薬理学会西南部会
    • Place of Presentation
      松山
    • Year and Date
      2009-11-20
    • Related Report
      2009 Final Research Report
  • [Presentation] Treatment with risperidone did not increase plasma nitric oxide metabolites levels in schizophrenic patients: a pilot study.2009

    • Author(s)
      Nakano Y, Yoshimura R, et al.
    • Organizer
      第19回日本臨床精神神経薬理学会
    • Place of Presentation
      京都
    • Year and Date
      2009-11-14
    • Related Report
      2009 Final Research Report
  • [Presentation] Varenicline did not increase serum BDNF levels in patients with nicotine dependence:a preliminary study.2009

    • Author(s)
      Nakano W, Yoshimura R, et al.
    • Organizer
      第19回日本臨床精神神経薬理学会
    • Place of Presentation
      京都
    • Year and Date
      2009-11-13
    • Related Report
      2009 Final Research Report
  • [Presentation] アルコール依存と脳由来神経栄養因子2009

    • Author(s)
      吉村玲児, ほか
    • Organizer
      第21回日本アルコール精神医学会
    • Place of Presentation
      横浜
    • Year and Date
      2009-09-07
    • Related Report
      2009 Final Research Report
  • [Presentation] アルコール依存と脳由来神経栄養因子2009

    • Author(s)
      吉村玲児
    • Organizer
      第21回日本アルコール精神医学会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      2009-09-07
    • Related Report
      2009 Annual Research Report
  • [Presentation] Social Adoptation Self-evaluation Scale(SASS)日本語版のうつ病患者における臨床的有用性の検討.2009

    • Author(s)
      中野英樹, ほか
    • Organizer
      第105回日本精神神経学会学術総会
    • Place of Presentation
      神戸
    • Year and Date
      2009-08-21
    • Related Report
      2009 Final Research Report
  • [Presentation] Alcohol dependence and depression:views from dynamics of brain-derived neurotrophic factor and catecholamines.2009

    • Author(s)
      Nakano W, Yoshimura R, et al.
    • Organizer
      Korean Society of Biol Psychiatry
    • Place of Presentation
      Seoul
    • Year and Date
      2009-07-31
    • Related Report
      2009 Final Research Report
  • [Presentation] うつ病寛解後の抗うつ薬の服薬コンプライアンス:血中薬物濃度を指標とした検討.2009

    • Author(s)
      吉村玲児, ほか
    • Organizer
      第6回うつ病学会総会
    • Place of Presentation
      東京
    • Year and Date
      2009-07-31
    • Related Report
      2009 Final Research Report
  • [Presentation] うつ病寛解後の抗うつ薬の服薬アドヒアランス:血中薬物濃度を指標とした検討.2009

    • Author(s)
      吉村玲児, ほか
    • Organizer
      第28回躁うつ病の薬理・生化学研究懇話会
    • Place of Presentation
      千歳
    • Year and Date
      2009-07-10
    • Related Report
      2009 Final Research Report
  • [Presentation] ミルナシプランが脳内の一酸化窒素動態及び脳由来神経栄養因子の発現に与える影響2009

    • Author(s)
      杉田篤子, 他
    • Organizer
      第28回躁うつ病の薬理・生化学研究懇話会
    • Place of Presentation
      千歳(丸駒温泉旅館)
    • Year and Date
      2009-07-10
    • Related Report
      2009 Annual Research Report
  • [Presentation] うつ病とアルコール依存症での抑うつ症状に対する抗うつ薬の効果.臨床精神薬理学的予備的検討.2009

    • Author(s)
      中野和歌子, ほか
    • Organizer
      第31回日本生物学的精神医学会
    • Place of Presentation
      京都
    • Year and Date
      2009-04-25
    • Related Report
      2009 Final Research Report
  • [Presentation] 脳内GABA濃度は外向性・開放性性格と関連する:3T MRSを用いた健常者での検討2009

    • Author(s)
      吉村玲児, 他
    • Organizer
      第31回日本生物学的精神医学会
    • Place of Presentation
      京都(京都国際会議場)
    • Year and Date
      2009-04-24
    • Related Report
      2009 Annual Research Report
  • [Presentation] 抗うつ薬は脳内一酸化窒素および脳由来神経栄養因子に与える影響2009

    • Author(s)
      杉田篤子, 他
    • Organizer
      第31回日本生物学的精神医学会
    • Place of Presentation
      京都(京都国際会議場)
    • Year and Date
      2009-04-23
    • Related Report
      2009 Annual Research Report
  • [Presentation] 心血管病およびうつ病成員における一酸化窒素システムの意義.2009

    • Author(s)
      筒井正人, ほか
    • Organizer
      第82回日本薬理学会年会シンポジウム
    • Place of Presentation
      横浜
    • Year and Date
      2009-03-16
    • Related Report
      2009 Final Research Report
  • [Presentation] ミルナシプランが脳内の一酸化窒素動態および脳由来神経栄養因子の発現に与える影響.2009

    • Author(s)
      杉田篤子, 吉村玲児, ほか
    • Organizer
      第28回躁うつ病の薬理・生化学研究懇話会
    • Place of Presentation
      千歳
    • Related Report
      2009 Final Research Report
  • [Presentation] Sertraline治療抵抗性うつ病に対する少量のrisperidone追加療法2008

    • Author(s)
      吉村玲児, 他
    • Organizer
      日本臨床精神薬理学会
    • Place of Presentation
      東京
    • Year and Date
      2008-10-03
    • Related Report
      2008 Annual Research Report
  • [Presentation] SSRIとSNRIの脳由来神経栄養因子(BDNF)、サイトカイン血中濃度に対する影響2007

    • Author(s)
      吉村 玲児
    • Organizer
      日本臨床精神薬理学会
    • Place of Presentation
      大阪
    • Year and Date
      2007-10-04
    • Related Report
      2007 Annual Research Report

URL: 

Published: 2007-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi